Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

China Shineway Pharmaceutical Group Ltd

C1S
Current price
1.08 EUR 0 EUR (0.00%)
Last closed 9.2 HKD
ISIN KYG2110P1000
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Berlin Exchange
Capitalization 7 311 667 176 HKD
Yield for 12 month +31.48 %
1Y
3Y
5Y
10Y
15Y
C1S
21.11.2021 - 28.11.2021

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products; and research and development of Chinese pharmaceutical products. The company was incorporated in 2002 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited operates as a subsidiary of BH Corporate Services Ltd. Address: No. 168, Shiluan Street, Shijiazhuang, China, 051430

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

115.51 HKD

P/E ratio

6.0818

Dividend Yield

5.92 %

Current Year

+4 927 855 161 HKD

Last Year

+4 310 416 960 HKD

Current Quarter

+2 310 729 471 HKD

Last Quarter

+2 617 125 689 HKD

Current Year

+3 703 218 443 HKD

Last Year

+3 205 903 686 HKD

Current Quarter

+1 734 976 661 HKD

Last Quarter

+1 968 241 782 HKD

Key Figures C1S

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 1 106 174 300 HKD
Operating Margin TTM 26.86 %
PE Ratio 6.0818
Return On Assets TTM 6.29 %
PEG Ratio
Return On Equity TTM 15.81 %
Wall Street Target Price 115.51 HKD
Revenue TTM 4 208 552 964 HKD
Book Value 9.72 HKD
Revenue Per Share TTM
Dividend Share 0.54 HKD
Quarterly Revenue Growth YOY -13 %
Dividend Yield 5.92 %
Gross Profit TTM 2 941 109 367 HKD
Earnings per share
Diluted Eps TTM
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY 27.6 %
Profit Margin 26.27 %

Dividend Analytics C1S

Dividend growth over 5 years

71 %

Continuous growth

1 year

Payout Ratio 5 years average

59 %

Dividend History C1S

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.58
Ex Dividend Date 10.09.2024
Forward Annual Dividend Yield 5.98 %
Last Split Factor
Payout Ratio 36.74 %
Last Split Date
Dividend Date

Stock Valuation C1S

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 6.0818
Forward PE
Enterprise Value Revenue 0.1994
Price Sales TTM 1.7373
Enterprise Value EBITDA 0.5837
Price Book MRQ 0.9163

Financials C1S

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators C1S

For 52 weeks

6.15 HKD 10.33 HKD
50 Day MA 8.76 HKD
Shares Short Prior Month
200 Day MA 8.68 HKD
Short Ratio
Shares Short
Short Percent